Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Website: pfizer.com


  • Bad financial results growth rate -14.4% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (0.8%)
  • Dividend yield for the last twelve months 6.9%
  • Free cash flow yield 7.8% (LTM)
  • Share price is 16.2% higher than minimum and 51.1% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (11.9x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: PFE
Share price, USD:  (-2.8%)25.095
year average price 24.87  


year start price 26.62 2024-12-27

min close price 21.59 2025-04-10

max close price 27.37 2025-10-03

current price 25.10 2025-12-26
Common stocks: 5 615 000 000

Dividend Yield:  6.9%
FCF Yield LTM: 7.8%
EV / LTM EBITDA: 11.9x
EV / EBITDA annualized: 9.4x
Last revenue growth (y/y):  -5.9%
Last growth of EBITDA (y/y):  -22.8%
Historical revenue growth:  -10.3%
Historical growth of EBITDA:  +11.8%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 140 908
Net Debt ($m): 47 023
EV (Enterprise Value): 187 931
EBITDA LTM ($m): 15 849
EV / LTM EBITDA: 11.9x
Price to Book: 1.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-12-23zacks.com

Pfizer (PFE) Stock Slides as Market Rises: Facts to Know Before You Trade

2025-12-19zacks.com

Pfizer Down After It Issues Muted 2026 Outlook: How to Play the Stock

2025-12-19seekingalpha.com

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

2025-12-17forbes.com

Pfizer Stock Can Sink More. Here Is How

2025-12-17zacks.com

Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future?

2025-12-17prnewswire.com

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

2025-12-16zacks.com

Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note

2025-12-16seekingalpha.com

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

2025-12-16youtube.com

Pfizer falls on disappointing guidance

2025-12-16proactiveinvestors.com

Pfizer shares fall after it forecasts 2026 revenue below estimates
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data